GE HealthCare Technologies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

GE HealthCare Technologies hat ein Gesamteigenkapital von $7.6B und eine Gesamtverschuldung von $9.3B, wodurch sich der Verschuldungsgrad auf 121.8% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $32.2B bzw. $24.6B. GE HealthCare Technologies Das EBIT des Unternehmens beträgt $2.9B, so dass der Zinsdeckungsgrad 5.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $2.6B.

Wichtige Informationen

121.8%

Verhältnis von Schulden zu Eigenkapital

US$9.26b

Verschuldung

Zinsdeckungsgrad	5.5x
Bargeld	US$2.55b
Eigenkapital	US$7.60b
Gesamtverbindlichkeiten	US$24.61b
Gesamtvermögen	US$32.21b

Jüngste Berichte zur Finanzlage

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

May 21

Recent updates

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

May 21

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

May 02

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate

Oct 23

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price

Jun 28

Some Confidence Is Lacking In GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) P/E

Apr 17

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: GEHCDie kurzfristigen Aktiva des Unternehmens ($9.4B) übersteigen seine kurzfristigen Passiva ($8.9B).

Langfristige Verbindlichkeiten: GEHCDie kurzfristigen Vermögenswerte des Unternehmens ($9.4B) decken seine langfristigen Verbindlichkeiten ($15.8B) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: GEHCDie Nettoverschuldung im Verhältnis zum Eigenkapital (88.2%) wird als hoch angesehen.

Schulden abbauen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob das Verhältnis von Schulden zu Eigenkapital in den letzten 5 Jahren gesunken ist ( GEHC).

Schuldendeckung: GEHCDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (22.2%).

Zinsdeckung: GEHCDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (5.5x Coverage) gut gedeckt.

GE HealthCare Technologies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

Recent updates

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

GE Healthcare Names Adam Holton as Chief People Officer

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

President & CEO of Imaging notifies of intention to sell stock

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Price target increased by 7.6% to US$90.21

Full year 2023 earnings: EPS misses analyst expectations

Now 33% overvalued after recent price rise

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year of 2024

GE HealthCare Q4 Earnings: Growth Lagging The Market

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

GE HealthCare Technologies Inc. Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

GE HealthCare Technologies Inc. to Report Q4, 2023 Results on Feb 06, 2024

Why GE HealthCare May Be Up To 50% Undervalued

GE HealthCare Technologies Inc. (NasdaqGS:GEHC) entered into definitive agreement to acquire MIM Software Inc.

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare Technologies Inc. Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

GE Healthcare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

GE HealthCare Technologies Inc. Announces to Showcase Some of the Latest Innovations Designed to Help Clinicians in the Treatment of Cardiovascular Disease At the 2023 Transcatheter Cardiovascular Therapeutics Conference

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate

GE HealthCare Technologies Inc. to Report Q3, 2023 Results on Oct 31, 2023

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Launches Enhanced Venue Family Ultrasound Systems Featuring AI-Driven Caption Guidance

GE HealthCare Technologies Inc. Announces Cash Dividend for Third Quarter of 2023, Payable on November 15, 2023

GE HealthCare Introduces Vscan Air SL, Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients

GE HealthCare Technologies Inc. Receives FDA Clearance for Portrait Mobile, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

CEO of Pharmaceutical Diagnostics notifies of intention to sell stock

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of US$0.03 per share at 0.1% yield

GE HealthCare Technologies Inc. to Report Q2, 2023 Results on Jul 25, 2023

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of Fiscal Year 2023, Payable on August 15, 2023

GE HealthCare Technologies Inc. Announces the First Patient Scanned in a Phase I Clinical Trial of a Fluorine-18 PET Radiopharmaceutical

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Releases Reimagining Better Health

GE HealthCare Introduces Sonic DL

GE HealthCare Technologies Inc. Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

GE HealthCare Technologies Inc. Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress

GE Healthcare Technologies Inc. Announces Chief Financial Officer Changes, Effective from June 1, 2023

Some Confidence Is Lacking In GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) P/E

CEO of Imaging recently sold US$444k worth of stock

GE HealthCare Technologies Inc. (NasdaqGS : GEHC) signed an agreement to acquire Caption Health, Inc.

Now 21% undervalued

Full year 2022 earnings: Revenues in line with analyst expectations

GE Healthcare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2023